30 Years – India’s Strategy Boutique
30 Years – India’s Strategy Boutique

Life Sciences (Pharma & Medtech)

Conducting a Market Assessment for Next Generation Sequencing Testing for Oncology in India

Back +

Client Challenge

The client, aiming to enter the Next Generation Sequencing (NGS) testing market with a focus on oncology, engaged UC to conduct a comprehensive market assessment of NGS testing in oncology in India.

Our Approach

UC adopted the following approach to address the client’s requirements:

  • Analyzed the current and future market opportunity (by volume and value) of NGS in oncology in India.
  • Evaluated the current and expected adoption rate and adoption funnel of NGS in oncology at different stages of the treatment cycle.
  • Identified factors driving the usage of NGS among clinicians at different stages of treatment and reasons for patient drop-off.
  • Assessed how the NGS landscape in oncology is evolving.
  • Identified key influencers for NGS in oncology and determined the most effective means to engage with primary and secondary influencers.
  • Analyzed the competition landscape for NGS in oncology, including key players, their positioning, success factors, and learnings from competitors.
  • Evaluated the existing reimbursement pathway and dossier submission process for NGS in oncology.
  • Assessed the current and future attractiveness of the NGS market in the oncology segment.

 

To gather insights, the UC team conducted extensive primary research involving approximately 90 respondents from various cities, including oncologists, diagnostic labs, and competitors.

Our Impact

The client was provided with the following insights and recommendations:

  • Market Size and Growth
    • Current and future market size for oncology samples using NGS.
    • Growth factors driving NGS adoption.
  • Segmentation and Behavior
    • Segmentation of NGS samples by type of lab, competition, panel size, etc.
    • Purchase behavior and installed capacity across different healthcare settings.
    • Oncology prescription behavior.
  • Cost and Regulatory Dynamics
    • Cost dynamics of NGS.
    • Regulatory dynamics of NGS.
  • Competitive Insights
    • Detailed competition and product insights.

These findings equipped the client with a comprehensive understanding of the NGS market in oncology in India, enabling informed decision-making for market entry.